Malassezia growth on peritumoral skin after routine methyl-5-aminolevulinate photodynamic therapy for actinic keratosis and nonmelanoma skin cancer
Actas Dermosifiliogr. 2015 Jan-Feb;106(1):70-1.
doi: 10.1016/j.ad.2014.04.010.
Epub 2014 Jul 31.
[Article in
English,
Spanish]
Affiliations
- 1 Unit of Dermatology, Hospital San Jorge, Huesca, Spain; Health Science Institute of Aragón, Zaragoza, Spain. Electronic address: ygilaberte@salud.aragon.es.
- 2 Health Science Institute of Aragón, Zaragoza, Spain; Microbiology Section, Hospital Royo Villanova, Zaragoza, Spain.
- 3 Laboratory of Microbiology, Municipal Institute of Public Health, Zaragoza, Spain.
- 4 Health Science Institute of Aragón, Zaragoza, Spain; IIS Aragón, Department of Microbiology, University Hospital Miguel Servet, University of Zaragoza, Zaragoza, Spain.
No abstract available
MeSH terms
-
Aminolevulinic Acid / analogs & derivatives*
-
Aminolevulinic Acid / pharmacology
-
Aminolevulinic Acid / therapeutic use
-
Dermatomycoses / complications*
-
Dermatomycoses / drug therapy*
-
Female
-
Humans
-
Keratosis, Actinic / complications*
-
Keratosis, Actinic / drug therapy*
-
Keratosis, Actinic / microbiology
-
Malassezia / drug effects*
-
Malassezia / growth & development*
-
Malassezia / isolation & purification
-
Male
-
Photochemotherapy*
-
Photosensitizing Agents / pharmacology
-
Photosensitizing Agents / therapeutic use*
-
Skin Neoplasms / complications*
-
Skin Neoplasms / drug therapy*
-
Skin Neoplasms / microbiology
Substances
-
Photosensitizing Agents
-
methyl 5-aminolevulinate
-
Aminolevulinic Acid